Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prophylactic Rituximab in Renal Transplantation
2007-001604-20Phase 2Completed
- Sponsor
- Radboud University Medical Center
- Start
- Jun 2007
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 2, randomised trial of rituximab in acute rejection (AR) (2 arms), sponsored by Radboud University Medical Center. Primary endpoints: Biopsy-confirmed acute rejection incidence and Biopsy-confirmed acute rejection severity. Started Jun 2007; status: completed.
02
Drugs
rituximab
03
Conditions
acute rejection (AR)
Beyond the preview
Go deeper on 2007-001604-20.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-001604-20.